Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Neuro-immunology
•
Neuro-infectious disease
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
Related Questions
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What antibiotics would you use for empiric treatment of a brain abscess in patients allergic to penicillin, metronidazole, and vancomycin?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
